Flerie AB (OSTO:FLERIE) Other Gross PPE : kr0.80 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Flerie AB Other Gross PPE?

Flerie AB's Other Gross PPE for the quarter that ended in Mar. 2025 was kr0.80 Mil.

Flerie AB's quarterly Other Gross PPE declined from Sep. 2024 (kr1.10 Mil) to Dec. 2024 (kr1.00 Mil) and declined from Dec. 2024 (kr1.00 Mil) to Mar. 2025 (kr0.80 Mil).

Flerie AB's annual Other Gross PPE declined from Dec. 2022 (kr2.04 Mil) to Dec. 2023 (kr1.00 Mil) and declined from Dec. 2023 (kr1.00 Mil) to Dec. 2024 (kr1.00 Mil).

Flerie AB Other Gross PPE Historical Data

The historical data trend for Flerie AB's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flerie AB Other Gross PPE Chart

Flerie AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Gross PPE

Get a 7-Day Free Trial

2.04

2.16

2.04

1.00

Flerie AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Gross PPE	Get a 7-Day Free Trial															2.47	1.30	1.10	1.00	0.80

Flerie AB Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Flerie AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Flerie AB (OSTO:FLERIE) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

1NP1:Germany

Address

Skeppsbron 16, Stockholm, SWE, 111 30

Website

https://www.flerie.com/en

Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.

Flerie AB Headlines

No Headlines